Skip to content
Find a clinic near me
Become a Provider

Tag: new york

triLift by Lumenis
Copyright © 2022 Lumenis Be Ltd. All Rights Reserved | Privacy Statement | Terms of Use | Safety Information | Patents | Cookie Settings |

*A course of 4 to 6 weekly treatments is recommended

*The testimonial describes a specific experience of a paid spokesperson. The experience of other people may vary.

**compared to baseline levels, for natural volume in a laboratory study Boisnic S, Branchet MC. Ex-vivo study of hybrid energy technology using a human skin model. Eur J Dermatol 2014; 24(1): 46-52 oi:10.1684/ejd.2013.2233. Ex vivo study results may not translate into actual clinical results.
Indication For Use: The triLift™ system is intended for dermatological procedures requiring ablation and resurfacing of the skin when using triFX™ Energy (Applicator VO), as well as intended for use in dermatologic and general surgical procedures for the non-invasive treatment of mild to moderate facial wrinkles and rhytides when using TriPollar® RF Energy (Applicators 1-3). The triLift with the DMSt™ mode is intended for muscle conditioning to stimulate healthy muscles. triLift with the DMSt™ mode is not intended to be used in conjunction with therapy or treatment of medical diseases or medical conditions of any kind. triLift is intended to be operated by a trained professional who is present to monitor treatment.

The following possible side effects can occur following triLift treatment:
Side effects may appear either at the time of treatment or shortly after. Side effects may include any of the following: prolonged or significant pain damage to natural skin texture (blister, burn), excessive skin redness (erythema), excessive swelling (edema), fragile skin bruising, excessive itching, change of pigmentation (hyper-pigmentation or hypopigmentation), scarring transient skin break-out such as acne and pimples. For complete list of contraindications, please refer to the User Manual.

Contraindications:
triLift is contraindicated for patients with pacemaker, defibrillator, or any implanted electronic device, metal implants in the treatment area.

PB-00043580 Rev B